Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 2, Issue 4, Page 1 (April 2006)

1 of 22 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (259 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

AD Therapy Eyes Nicotinic Receptors

MICHELE G. SULLIVAN (Mid-Atlantic Bureau)

A new class of drugs under development for Alzheimer's disease has taken a cue from one of the world's oldest drugs—nicotine.

PII: S1553-3212(06)71480-7

doi:10.1016/S1553-3212(06)71480-7

1 of 22 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.